The present study was designed to develop an animal model of hypertension and cardiac hypertrophy associated with obesity in female rats. Furthermore, we studied the involvement of the natriuretic peptide system in the mechanisms of these conditions. Obesity was induced in Wistar rats by a high fat diet and ovariectomy. The rats were divided into four groups: ovariectomized or sham-operated with high-fat diet and ovariectomized or sham-operated with control diet. After 24 weeks of diet, rats were killed, and their tissues were removed. Cardiac atrial natriuretic peptide (ANP), clearance receptor (NPr-C) gene expression was determined by PCR. ANP concentrations were measured in plasma. Ovariectomized fat-fed rats (OF) showed increased body weight, visceral fat depot and blood pressure and decreased sodium excretion compared to other groups. Also, these rats showed higher heart-to-body weight and cell diameters of ventricular cardiomyocytes and lower cardiac ANP mRNA and plasma ANP than the control group. The adipocyte and renal NPr-C mRNA of OF rats were higher than the control group. These data showed that combined ovariectomy and high fat diet elicited obesity, hypertension and cardiac hypertrophy. These results suggest that the impairment of the natriuretic peptide system may be one of the mechanisms involved not only in development of hypertension but also in cardiac hypertrophy associated with obesity in ovariectomized rats.
Introduction
Obesity is a major challenge for basic scientific and clinical research because it represents an important risk for serious diet-related chronic diseases including cardiovascular disease. Among other factors, obesity is an important contributor to hypertension in humans, and it is associated with salt retention [1] , especially in postmenopausal women. Data from the Framingham Heart Study suggest that 65% of essential hypertension in women can be directly attributed to obesity [2] . Cardiovascular diseases are the leading cause of death in women, and the vast majority of them occur in postmenopausal women [3] . Also, postmenopausal women are characterized by higher abdominal fat mass accumulation compared with premenopausal women [4] .
Hypertension commonly leads to ventricular hypertrophy, which is a major risk factor for the development of heart failure [5] . Clinical and experimental studies have established that sex influences the patterns of ventricular hypertrophy [6] . In fact, the incidence of hypertrophy in postmenopausal women exceeds that of age-matched men [7] and it can be reversed by hormone replacement therapy [8] , suggesting that estrogen may oppose developmental events in the cardiomyocyte that generate hypertrophy. The mechanisms that link obesity with high blood pressure, cardiac hypertrophy and postmenopausal status have not been fully elucidated. Despite well-established models of hypertension, suitable animal models to study postmenopausal hypertension and myocardial hypertrophy associated with obesity are lacking. The ideal model would not only have the features of human hypertension but also allow the study of changes in cardiovascular function that occur with weight gain and estrogen loss. The diet-induced obese animal models appear to be the most relevant with regard to human obesity. Some studies have revealed that high-fat diets promote hypertension [5] and activation of the systemic renin-angiotensin system [9] . Unfortunately, these studies utilized only male animals and most studies using female animals failed to show obesity hypertension and cardiac hypertrophy induced by highfat diet [10] [11] [12] .
It has been suggested that renal sodium retention and increased activation of the sympathetic system may contribute to the development Regulatory Peptides 167 (2011) [149] [150] [151] [152] [153] [154] [155] of hypertension in obese subjects [13] . Other mechanisms, such as the natriuretic peptide system, have also been suggested to cause obesityrelated hypertension. Some authors hypothesized that obese individuals may have an impaired natriuretic response [14, 15] . Atrial natriuretic peptide (ANP) is a hormone mainly secreted by atrial cardiomyocytes in response to mechanical stretch [16] . ANP is involved in the regulation of blood pressure and blood volume and markedly stimulates diuresis and natriuresis [17] . In experimental models caloric deprivation through fasting decreases NPr-C, the receptor involved in clearance of the peptide; and consequently results in increased circulating ANP levels [18] . In obese men, during weight reduction, the decrease in blood pressure is accompanied by an increase in natriuresis and correlates to downregulation of adipocyte NPr-C [19] , suggesting that subsequently elevated ANP can contribute to blood pressure reduction in obese subjects.
Besides its role in regulation of blood pressure and blood volume, ANP is a direct moderator of cellular growth, and it plays an important autocrine role in the heart as an inhibitor of cardiac hypertrophy [20] . However, impaired expression of the ANP gene results in cardiac hypertrophy [21] . The purpose of the present study was to develop an animal model of hypertension and cardiac hypertrophy associated with obesity induced by high fat diet and ovariectomy. Furthermore, we tested the hypothesis that the impairment of natriuretic peptide system may contribute not only to development of obesity hypertension but also to cardiac hypertrophy in ovariectomized fat-fed rats.
Methods

Animals
The study was approved by the "Ethics Committee in Animal Experimentation of the Estadual University of Feira de Santana" and carried out according to the recommendations of the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Female Wistar rats weighting 150-200 g were obtained from ICS-UFBA (Salvador, BA, Brazil). The animals (6 per cage) were maintained under controlled light and temperature conditions (lights on from 07:00 to 19:00 h, 23±3°C) and had free access to tap water and a standard rat chow (AIN 93; Pragsoluções, Brazil). The animals were ovariectomized or sham-operated using ketamine 50 mg/kg and xylazine 5 mg/kg (im). The animals received a prophylactic antibiotic injection (pentabiotic, FontouraWyeth, 0.4 ml/animal/im).
Diet protocol
After 1-week acclimation, rats were randomly divided into four groups: ovariectomized with high-fat diet (OF, n=6), sham-operated with high-fat diet (SF, n=6), ovariectomized with control diet (OC, n=6) or sham-operated with control diet as the control group (SC, n=6). Diets were manufactured by Pragsoluções (São Paulo, SP, Brazil). The composition of the diets [22] is listed on Table 1 . All rats were maintained on their diet for 24 weeks.
Experimental procedures
At the end of every week in the entire study period, body weight and blood pressure were measured. At 0, 6, 12 and 24 weeks, the rats were placed in metabolic cages to collect 24-h urine samples and measure food intake over four days. Blood and urine samples were collected to quantify sodium and creatinine levels. At the end of the study, rats were sacrificed by decapitation and blood was collected in tubes containing 10 − 5 mol/L EDTA 10 Louis, MO, USA). Heart, uterus, kidneys and fat depots (mesenteric and parametrial) were removed, weighed, and snap frozen in liquid nitrogen.
Systolic, diastolic and mean blood pressure and heart rate
The onset and development of hypertension were assessed with the tail-cuff method using a LE5001 Electro-Sphygmomanometer (Panlab, Barcelona, Spain) after the rats were warmed at 35°C for 5 min. Heart rate and mean blood pressure were measured under conscious conditions at the end of every week of the diet. The average of six pressure readings was recorded for each measurement.
Radioimmunoassay
The plasma ANP levels were determined by radioimmunoassay as previously described [23] . ANP antibody was kindly donated by Dr. Jolanta Gutkowska (CHUM-Université de Montreal, Montreal, Canada).
Measurement of cardiomyocyte diameter and fibrosis
Hearts were placed in 10% formaldehyde and embedded in paraffin. Transverse sections (4 μm thick) of the ventricles were stained with hematoxylin and eosin stain or Masson's trichrome. The images were captured using Adobe Photoshop 4.0 imaging software followed by analysis using Image Pro Plus 4.1 imaging software (Media Cybernetics, Silver Spring, MD). Approximately 50 cardiomyocytes were selected from the five to seven images captured at different sites, and one average value of the cross-sectional diameter for the heart was calculated for each animal. Also, for each animal, one average value for fibrosis of the heart was calculated.
Renal function studies
The rats were placed in metabolic cages during four days to collect 24-h urine and blood samples, which were used to measure levels of creatinine and sodium. Plasma creatinine was measured by the Jaffé method [24] , whereas the levels of sodium were measured using a flame photometer (Mod. 910, Analyser, SP, Brazil). Glomerular filtration rate (GFR) was estimated by calculating creatinine clearance.
RNA extraction and PCR
RNA from heart, adipose tissue and kidney was extracted using Trizol reagent following the supplier's protocol. Using MMLV reverse transcriptase under standard conditions in a 20 μl reaction, 2 μg of RNA was reverse transcribed. For amplifying ANP the oligonucleotides 5′-GCCGGTAGAAGATGAGGTCA and 5′-GGGCTCCAATCCTGTCAATC were used as forward and reverse primers [25] , respectively. The forward and reverse primers used for amplifying NPr-C were 5′-GCGAAGCCTGAGTTTGAGAA-3′ and 5′-ATACCGATCCCCATTAG-CAT-3′ [25] . Primers were manufactured by Prodimol Biotechnology (Belo Horizonte, Brazil). The PCR amplifications were performed at 95°C, 5 min followed by 29 cycles at 94°C, 30 s; 60°C, 45 s; and 72°C, 1 min for ANP, and 31 cycles at 94°C, 30 s; 58°C, 45 s; and 72°C, 1 min for NPr-C. Final extension was for 10 min. All reaction products were separated on a 1.5% agarose gel and stained with ethidium bromide. β-Actin was amplified as an internal control in each PCR test using specific primers [26] to provide a semi-quantitative assessment.
The result is an average of three PCR reactions.
Statistical analysis
Data were expressed as mean ± SEM and analyzed using GraphPad software. Data were compared using one-way ANOVA followed by Newman-Keuls post-hoc test or two-way ANOVA followed by Bonferroni post-test. Correlations were calculated using two-tailed Pearson's correlation coefficients. Data was considered statistically significant at the p b 0.05 level.
Results
Body weight, caloric intake and organ mass
The body weights (BW) for SC, SF, OC and OF rats were measured weekly. Initial mean BWs of the four groups did not differ significantly (Table 2) . Ovariectomized fat-fed rats had significantly higher BW than control rats starting at month 2 and remaining higher throughout the 16-week dietary period (Fig. 1) . At month 5, the BWs of SF and OC rats were significantly greater than those of control rats (Fig. 1) . Ovariectomy or high fat diet enhanced more than 3-fold the body weight gain compared to the control rats. A combination of both ovariectomy and high fat diet, increased the body weight gain by almost 6-fold compared to the control rats (Table 2) .
At the end of 24 weeks of the diet, the sum of visceral fat pads was greater in all groups compared with control rats (Table 2 ). There was no difference in feed consumption between the groups (data not shown), but due to greater caloric density of the high-fat diet, caloric intake was higher for high-fat diet groups compared with the standard diet groups ( Table 2) .
As expected, the uterine weight decreased in both ovariectomized groups (0.48 ± 0.05 and 0.30 ± 0.05 versus 2.28 ± 0.33 mg/g BW of SC, p b 0.05), due to lack of ovarian hormones. There were no differences in kidney weights among the four groups (data not shown).
Blood pressure and heart rate
The initial mean blood pressure was 91 ± 3 mmHg for all of the rats used in the experiment. After five months of the diet, the mean blood pressure of OF rats was 112 ± 3 mmHg, which was significantly higher than that of either OC (92 ± 3 mmHg), SF (94 ± 3 mmHg) or control SC (92 ± 4 mmHg) groups ( Fig. 2A) . The heart rate was not significantly different among groups (data not shown). A direct correlation was observed between body weight and mean blood pressure (p = 0.0062) (Fig. 2B ).
Renal function and natriuretic peptide system
Plasma creatinine, urine flow and GFR did not differ between experimental groups (data not shown). The fractional excretion of sodium (FENa+) decreased in ovariectomized fat-fed rats compared with other groups (Table 2 ). An inverse correlation was observed between mean blood pressure and FENa+ in ovariectomized rats (r = −0.689, p=0.003).
For testing the hypothesis that the increase of adipose tissue mass can lead to an amplified expression of NPr-C, we compared the status of gene expression by PCR. Ovariectomized rats presented higher NPr-C mRNA in visceral fat depot than control rats. No change was observed in adipocyte NPr-C mRNA in sham-operated control dietfed group (Fig. 4 ). An inverse correlation was observed between adipocyte NPr-C gene expression and FENa+ in ovariectomized rats (r = − 0.775, p = 0.024). Ovariectomized fat-fed rats presented higher renal NPr-C gene expression than the control rats. No change was observed in renal NPr-C gene expression in SF and OC groups (Fig. 4) . Plasma ANP level of ovariectomized fat-fed rats were lower Table 2 Comparison of weight gain, visceral fat weights, heart weights, caloric intake and fractional sodium excretion between control diet and high-fat diet female Wistar rats. Values are the mean ± SEM, n: 4 or 6 rats/group. than all other groups (Fig. 3) . Also, the ANP gene expression in both right and left atria of ovariectomized and fat-fed rats was lower than in the control group (Fig. 5) .
Cardiac and cardiomyocyte morphology
The relative heart weight of ovariectomized and fat-fed rats was significantly increased compared with the control group (Table 1) .
Morphological and histological analysis of hearts revealed a concentric ventricular hypertrophy along with increased cardiomyocyte diameter in the ovariectomized fat-fed rats compared to the other groups (Fig. 6B, C) In Fig. 6A , representative mid-region transverse sections show that cardiac enlargement in the OF rats was associated with reduced chamber lumen and increased wall thickness, indicative of concentric hypertrophy. In addition, ventricular expression of ANP mRNA was found to be decreased in ovariectomized fat-fed rats (Fig. 5 ). An inverse correlation was observed between ventricular ANP gene expression and heart weight in ovariectomized rats (r = − 0.832, 
Discussion
Female Wistar rats, ovariectomized and fed a diet with high-fat content, were used in a model of obesity-related hypertension similar to that observed in menopause. We have examined the effects of ovariectomy and/or high-calorie diet on body and fat mass gain, blood pressure, renal function, cardiac weight and natriuretic peptide system. We found that: (1) either high-fat diet or ovariectomy induced a similar increase in visceral fat mass and body weight; (2) the ovariectomy but not the high-fat diet decreased ANP synthesis; and (3) the high-fat diet plus ovariectomy induced heart hypertrophy, increased mean blood pressure, increased visceral fat mass and NPr-C gene expression; and decreased excretion of sodium, plasma ANP levels and cardiac ANP gene expression. These findings showed that high-fat diet or ovariectomy alone did not induce the alterations that occur in obesity-related hypertension. On the other hand, these two conditions together are able to promote some cardiovascular and renal changes similar to those observed in obese hypertensive humans and showed a probable link between the endocrine cardiac function and fat mass that can contribute to development of both hypertension and cardiac hypertrophy in females.
The elucidation of mechanisms responsible for postmenopausal hypertension and obesity has been stunted by lack of appropriate animal models. Old female SHR or ovariectomized SHR mice gain little weight with age or ovarian loss [27] . The FORKO mouse has weight gain and low plasma estradiol levels but does not exhibit increased oxidative stress, endothelial dysfunction or cardiac hypertrophy [28] , factors common to postmenopausal women. Some studies have revealed that high-fat diets promote obesity-related hypertension in male animals [9, 10] . However, most studies using female animals failed to show obesity-related hypertension induced by high-fat diet [11] [12] [13] , probably due to the protective effect of estrogen in the cardiovascular system [29] .
It is evident from animal experiments that the percentage of energy derived from fat in the diet is positively correlated with body fat content. Our results showed that a high-fat diet induces increased body weight and visceral fat mass. Interestingly, the ovariectomized rats showed similar body and fat depot weights when compared to high-fat diet sham-operated animals, despite their similar feed consumption. Some studies show that only the ovariectomy alone causes weight increase, regardless of diet. This suggests that the lack of estrogen modifies the body metabolic rate, reducing energy expenditure and causing the accumulation of fat [30] . In fact, crosssectional studies have suggested that decreases in resting metabolic rate may be accelerated in the postmenopausal years [31] .
In spite of similar fat mass gain, only the ovariectomized fat-fed rats presented increased blood pressure compared with the high-fat diet sham-operated animals. This response is probably due the lack of estrogen rather than weight gain. The loss of estrogen associated with menopause can increase the prevalence of various cardiovascular disease risk factors, including elevated blood pressure. Previous investigations have indicated that postmenopausal women are more than twice as likely to be hypertensive as premenopausal women [32] . Xu et al. demonstrated that both blood pressure and body weight in ovariectomized rats were significantly higher than in sham rats [33] . However, their study failed to show cardiac hypertrophy and hypertension when systolic blood pressure in the ovariectomized rats was within normal limits. However, Xu et al. showed that estrogen deficiency decreases plasma ANP levels in ovariectomized rats, and estrogen treatment can reverse this effect. In our study, the ovariectomized groups showed lower cardiac ANP gene expression and plasma ANP levels than in control groups. Estrogen affects the cardiac natriuretic peptide system by stimulating ANP release [34] and by increasing gene expression and production of atrial ANP [34, 35] . ANP seems to be a mediator of estradiol-related cardiovascular effects. Our previous study showed a high correlation between plasma ANP levels and decrease in blood pressure in estradiol-treated SHR [34] . The effect of ANP on the regulation of blood pressure is well known. ANP defends against excess salt and water retention, inhibits the production and action of vasoconstrictor peptides and blocks sympathetic outflow [16] . These actions lead to a reduction in blood pressure. Interestingly, the ovariectomized fat-fed rats showed lower ANP levels than ovariectomized control diet-fed rats, indicating an additional effect of high-fat diet on ANP levels.
The ovariectomized fat-fed rats presented the highest body weight and visceral fat mass and showed higher adipocyte and renal NPr-C gene expression than the other groups. Also, these animals had higher blood pressure compared with the control group. These results indicate that the high-caloric diet plus ovariectomy elicit obesityrelated hypertension in female rats. The increased visceral fat mass and blood pressure were strongly correlated with increased NPr-C gene expression. Recent findings point to a potential role of fat tissue in the development of obesity-related hypertension, such as the possible influence of adipose tissue on the natriuretic peptide system.
Findings from Sarzani et al. revealed that fasting inhibited adipose tissue NPr-C in rats, suggesting a nutritional influence on the expression of natriuretic peptide receptors [36] . Elevated NPr-C gene expression has been documented in adipose tissue of humans with obesity and hypertension; and allelic variants of this gene have been associated with lower plasma ANP levels [14, 15] . Increased expression of the NPr-C in adipose tissue may counteract the natriuretic and vasodilatory effects of natriuretic peptides and thereby promote the development of hypertension. Thus, the upregulation of NPr-C not only in adipose tissue but also in kidney tissue during weight gain may provide a reasonable explanation for the antinatriuresis observed in our study. Furthermore, obesity is associated with increased renal sodium reabsorption [37] . ANP induces natriuresis through a direct effect on the proximal renal tubule and an inhibition of distal sodium reabsorption through sodium epithelial channels [38] . It is possible that the impaired natriuretic peptide response in ovariectomized fat-fed rats may partly cause renal sodium retention, evidenced by a decrease in sodium excretion. The findings described in our study are consistent with the hypothesis that increased total adipose mass in obese animals influences the activity of natriuretic peptides. The mechanism is likely through enhanced expression of the NPr-C capturing more molecules of circulating ANP, preventing them from binding to biologically active receptors. In our study, we observed an inverse correlation between adipocyte NPr-C gene expression and sodium excretion. Therefore, impairment of the natriuretic peptide system likely contributes to hypertension observed in our study.
Given the possibility of involvement of ANP in cardiac remodeling, we aimed to elucidate this function using histological assessment. Cardiomyocyte dimensions indicate that cellular hypertrophy in ovariectomized fat-fed hearts is prominent. Cardiac hypertrophy in ovariectomized fat-fed rats was accompanied by decreased ventricular ANP gene expression. Several genetically altered models of the natriuretic peptide system provide evidence for anti-hypertrophic actions of ANP [21, 39] . Ventricular hypertrophy seen in natriuretic peptide receptor type-A (NPR-A) knockout mice appears to reflect the loss of a direct anti-hypertrophic effect of ANP in the heart. Pharmacological control of blood pressure in these animals was not able to reverse ventricular hypertrophy [40] . On the other hand, cardiac-specific over expression of NPR-A in the hearts of the NPR-A knockout mice results in myocyte size reduction [41] . It is possible that reduced ANP synthesis and liberation shown in ovariectomized fatfed rats not only act in a compensatory mechanism but also directly contribute to cardiac hypertrophy. Taken together, we propose that down-regulation of atrial natriuretic peptide expression may be involved not only in the development of hypertension but also in cardiac hypertrophy of ovariectomized fat-fed rats. Our findings indicate that a high-fat diet plus ovariectomy promote decreased synthesis and increased depuration of ANP, which generate obesity-related hypertension in female animals. Also, our model showed that cardiac hypertrophy is associated with reduced ventricular ANP gene expression and plasma ANP levels. Our results are the first to suggest that abundance of NPr-C in adipose and kidney tissue and reduced ANP synthesis play a significant role in explaining the development of cardiac hypertrophy in obesity; even with the systolic blood pressure within normal limits. This work paves the way for future animal studies aimed at determining the impact of weight gain and estrogen loss not only on the development of obesityrelated hypertension but also in cardiac hypertrophy in females. This model may be useful in studying other pathologies and conditions associated with obesity-related hypertension, such as alterations in kidney structure, the role of hormone replacement therapy in these conditions, the impact on the natriuretic peptide system and cardiac hypertrophy in pharmacologic correction of hypertension. Because the renin-angiotensin-aldosterone system may be directly involved in the development of both hypertension and cardiac hypertrophy, our model also can be used to study this system in these conditions.
